1,052 results on '"Kaufmann, Manfred"'
Search Results
202. Response-Guided Neoadjuvant Chemotherapy for Breast Cancer
203. Antitumor Effect of MAb EMD 55900 Depends on EGF-R Expression and Histopathology1
204. The nannoplankton diversity around Madeira. A first contribution
205. The influence of Great Meteor Seamount on the distribution of phytoplankton
206. Breast carcinoma during pregnancy: International Recommendations from An Expert Meeting
207. TARGIT-A trial: Updated results for local recurrence and survival for the German centers.
208. Integrating mitigation and adaptation into development: the case ofJatropha curcasin sub-Saharan Africa
209. Population structure of short-finned pilot whales in the oceanic archipelago of Madeira based on photo-identification and genetic analyses: implications for conservation
210. Side Effects of Standard Adjuvant and Neoadjuvant Chemotherapy Regimens According to Age Groups in Primary Breast Cancer
211. New Invertebrate Vectors of Okadaic Acid from the North AtlanticWaters--Portugal (Azores and Madeira) and Morocco.
212. Dose-finding of a fixed dose XM22 in patients with breast cancer receiving 4 cycles of chemotherapy versus 6 mg Neulasta®
213. Prognostic and predictive impact of Ki-67 before and after neoadjuvant chemotherapy on PCR and survival: Results of the GeparTrio trial.
214. Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
215. Lapatinib in HER2+ early breast cancer: Quality of life analysis.
216. Adjuvant lapatinib in women with early-stage HER2-positive breast cancer (HER2+ BC): Analysis of the hormone receptor-negative subgroup of the intent-to-treat (ITT) population of the TEACH trial.
217. Capecitabine Monotherapy: Review of Studies in First-Line HER-2-Negative Metastatic Breast Cancer
218. Homogeneous Datasets of Triple Negative Breast Cancers Enable the Identification of Novel Prognostic and Predictive Signatures
219. Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer
220. A clinically relevant gene signature in triple negative and basal-like breast cancer
221. A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors
222. The GISS Trial: a Phase II Prevention Trial of Screening Plus Goserelin, Ibandronate, versus Screening Alone in Premenopausal Women at Increased Risk of Breast Cancer
223. Re-Structuring of Marine Communities Exposed to Environmental Change: A Global Study on the Interactive Effects of Species and Functional Richness
224. Zurich Consensus: Statement of German Experts on St. Gallen Conference 2011 on Primary Breast Cancer (Zurich 2011)
225. Pregnancy after the calcium ionophore correction of pronuclei position in oocytes after intracytoplasmic sperm injection
226. Dose escalation and pharmacokinetic study of AEZS-108 (AN-152), an LHRH agonist linked to doxorubicin, in women with LHRH receptor-positive tumors
227. Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials
228. Polo-Like Kinase 1 as Predictive Marker and Therapeutic Target for Radiotherapy in Rectal Cancer
229. Comparison of critical limits for crop plant growth based on different indicators for the state of soil compaction
230. Capecitabine in Addition to Anthracycline- and Taxane-Based Neoadjuvant Treatment in Patients With Primary Breast Cancer: Phase III GeparQuattro Study
231. Neoadjuvant Treatment With Trastuzumab in HER2-Positive Breast Cancer: Results From the GeparQuattro Study
232. Biological impact of freezing Plk1 in its inactive conformation in cancer cells
233. Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
234. Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: Results of a randomised trial (GABG-IV E-93) – The German Adjuvant Breast Cancer Group
235. Breast Cancer Proteomics – Differences in Protein Expression between Estrogen Receptor-Positive and -Negative Tumors Identified by Tandem Mass Tag Technology
236. Neoadjuvant Chemotherapy Shows Similar Response in Patients With Inflammatory or Locally Advanced Breast Cancer When Compared With Operable Breast Cancer: A Secondary Analysis of the GeparTrio Trial Data
237. Local–regional richness relationship in fouling assemblages – Effects of succession
238. Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy
239. Data driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancer
240. Trastuzumab Beyond Progression in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A German Breast Group 26/Breast International Group 03-05 Study
241. T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers
242. Imaging Studies for the Early Detection of Breast Cancer: Imaging Is Not Sufficient
243. Loss of Plexin B1 is highly prognostic in low proliferating ER positive breast cancers – Results of a large scale microarray analysis
244. Long-term downregulation of Polo-like kinase 1 increases the cyclin-dependent kinase inhibitor p21WAF1/CIP1
245. Zurich Consensus: German Expert Opinion on the St. Gallen Votes on 15 March 2009 (11th International Conference at St. Gallen: Primary Therapy of Early Breast Cancer)
246. Targeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol
247. Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials
248. Umbilical endometriosis in pregnancy without previous surgery
249. Prognostic relevance of glucosylceramide synthase (GCS) expression in breast cancer
250. Understanding the data, meeting patients’ needs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.